The size of the parenteral nutrition market is expected to reach

LOS ANGELES, Dec. 26, 2022 (GLOBE NEWSWIRE) — The Global Parenteral Nutrition Market The size represented $6.231 billion in 2021 and is estimated to reach a market size of $10.306 billion by 2030, growing at a CAGR of 5.9% between 2022 and 2030.

Parenteral Nutrition Market Statistics

  • Global parenteral nutrition market revenue was worth USD 6.231 billion in 2021, with a CAGR of 5.9% from 2022 to 2030
  • North America parenteral nutrition market share exceeded 39.2% in 2021
  • Asia-Pacific parenteral nutrition market growth is expected to expand at a CAGR of 6.6% between 2022 and 2030
  • By consumer, the adult category captures over 57.7% of the total market share in 2021
  • Increasing prevalence of child malnutrition drives parenteral nutrition market value

Free Sample Report Request @ https://www.acumenresearchandconsulting.com/request-sample/1282

Parenteral Nutrition Market Report Coverage:

Market Parenteral Nutrition Market
Parenteral Nutrition Market Size 2021 USD 6.231 Million
Parenteral Nutrition Market Forecast 2030 USD 10,306 Million
Parenteral Nutrition Market CAGR During 2022 – 2030 5.9%
Parenteral Nutrition Market Analysis period 2018 – 2030
Parenteral Nutrition Market base year 2021
Parenteral Nutrition Market forecast data 2022 – 2030
segments covered By type of nutrient, by consumer, by end use and by geography
Parenteral Nutrition Market Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
Key companies profiled Actavis, Inc., B. Braun Melsungen AG, Aculife (Nirlife), Sichuan Kelun Pharmaceutical Co. Ltd., Baxter International, Inc., Hospira, Inc., Grifols International SA, Otsuka Pharmaceutical Factory, Inc., Fresenius Kabi AG, and Vifor Pharma.
Report Coverage Market trends, drivers, restraints, competitive analysis, player profiles, regulation analysis

Parenteral Nutrition Market Overview

Parenteral nutrition (NP) items are produced by pro-pharmaceutical aggravating companies and are considered higher risk in pharmaceutical management as they cannot go through any type of final cleaning. The participant received incredibly complex nutritional formulas that include additives such as salts, glucose, lipids, amino acids, and other essential nutrients and essential minerals. Parenteral nutrition is also known as total nutrient mixture (TNA), as well as total parenteral nutrition (TPN) when crucial nutrition is not obtained through other routes, and partial parenteral nutrition (PPN) when nutrition is also partially enteral. . When regulated through vein accessibility in an extremity rather than a focal vein as in central venous nutrition, it may be referred to as NPP.

Parenteral Nutrition Market Trends

The continued development of fertility and preterm birth rates will increase the expansion of the parenteral nutrition market. Increased awareness of parenteral nutrition through governmental and non-profit initiatives has resulted in increased demand in the global patient population for preventative medicine, and therefore for parenteral nutrition products. The increasing prevalence of chronic diseases, eg diabetes, in recent years, and increasing malnutrition trends around the world, fundamentally fuel interest in various parenteral nutrition products around the world. Additionally, rising fertility rates and a higher proportion of preterm births could boost market demand during forecast years.

The high prevalence of chronic diseases, eg, disease, is relied upon to promote the use of parenteral administration through chemotherapy sessions, although this modality of therapy causes a basic lack of nutrition, appetite, and vigor. Parenteral nutrition effectively addresses these concerns in patients receiving chemotherapy and in people with other chronic diseases where oral nutrition is impossible or insufficient. Parenteral nutrition successfully overcomes the risk of gastronomic discomfort in this method, contributing to its growing popularity. Although this is an intrusive operation, the risks of polluting the organization and publicizing such events may limit market growth to a modest extent.

Consult the detailed index of the report @

https://www.acumenresearchandconsulting.com/table-of-content/parenteral-nutrition-market

Parenteral Nutrition Market Segmentation

The global parenteral nutrition market has been segmented by insightful research and consulting based on nutrient type, consumer, and end use. By nutrient type, the segment is separated into carbohydrates, single-dose amino acid solution, vitamins and minerals, trace elements, and parenteral lipid emulsion. According to the parenteral nutrition market forecast, the single-dose amino acid solutions category is anticipated to develop significantly in the coming years.

In terms of consumption, the market is classified into adults, children and newborns. Furthermore, the market is divided into clinics, hospitals, home care, and others, based on end use. Regional overview of the parenteral nutrition market

Based on the region, the global parenteral nutrition market segmentation is into Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. According to an analysis of the parenteral nutrition industry, North America leads the market in 2021. The US market is expected to grow at a CAGR of 4% over the forecast time frame. The United States represents a significant provincial market share desired by Canada. Due to rising human operating costs, increased public awareness of parenteral nutrition products, and the increasing prevalence of heart disease, the region will experience profitable growth. Improving the national insurance regime, establishing and expanding the medical center area, and proximity to real industry players such as B. Braun, with a rapidly expanding business led by universal pediatric nutritionists, will increase local market share. As a result, the above-mentioned factors will drive the expansion of the parenteral nutrition market.

The market in Asia-Pacific is likely to be driven by factors such as the high prevalence of chronic kidney disease in densely populated countries such as China and India, rapid advances in social security, increased access to medical facilities, and rising consumption. per capita of human services in the region. The broad base of pharmaceutical organizations in countries like India, Japan and China further drives the industry in the region. Developing economies and expanding pharmaceutical markets in countries like China, Indonesia, Singapore, India, Taiwan, and Malaysia are expected to boost the Asia-Pacific market. Rising rates of preterm births, which cause malnutrition, are driving the use of parenteral nutrition in the Asia-Pacific region.

Buy this premium research report:

https://www.acumenresearchandconsulting.com/buy-now/0/1282

Parenteral Nutrition Market Players

Some of the prominent companies in the parenteral nutrition market include Actavis, Inc., Aculife (Nirlife), Otsuka Pharmaceutical Factory, Inc., Baxter International, Inc., Grifols International SA, Fresenius Kabi AG, B. Braun Melsungen AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co. Ltd., and Vifor Pharma.

Questions answered by this report

  • What was the market size of the Parenteral Nutrition Market in 2021?
  • What will be the CAGR of the Parenteral Nutrition market during the forecast period from 2022 to 2030?
  • Who are the leading vendors in the global Parenteral Nutrition market?
  • Which region held the highest share of the Parenteral Nutrition market in 2021?
  • What are the key drivers of the Parenteral Nutrition market?
  • Who is the largest End User Parenteral Nutrition market?
  • What will be the value of Parenteral Nutrition market in 2030?

Explore more research topics at Medical Related reports:

the global Healthcare Predictive Analytics Market the size was valued at USD 9.496 Million in 2021 and it is estimated that it will reach USD 87.494 Million by 2030, in a TACC of 28.2% from 2022 to 2030.

the global Sexual Wellness Market the size was valued at $80.1 billion in 2021 and it is estimated that it will reach $121.6 billion by 2030, growing at a rate CAGR of 4.8% from 2022 to 2030.

the global neurotechnology device market the size was valued at USD 10,796 Million in 2021 and is expected to reach USD 34,761 Million by 2030, with a significant TACC of 14.3% from 2022 to 2030.

On Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market intelligence and consulting services to the information technology, investment, telecommunications, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives make fact-based decisions about technology purchases and develop strong growth strategies to sustain market competition. With a team of more than 100 analysts and collective industry experience of more than 200 years, Acumen Research and Consulting claims to offer a combination of industry knowledge along with global and national experience.

For the latest update, please follow us on Twitter , instagram Y LinkedIn

Contact Us:

Mr Richard Johnson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

Email: sales@acumenresearchandconsulting.com

Leave a Reply

Your email address will not be published. Required fields are marked *